These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39035099)

  • 1. Prognostic role of TEAD4 in TNBC: in-silico inhibition of the TEAD4-YAP interaction by flufenamic acid analogs.
    Gupta SRR; Singh S; Rustagi V; Pahuja M; Mangangcha IR; Rinchui M; Jha SK; Singh A; Singh IK
    In Silico Pharmacol; 2024; 12(2):64. PubMed ID: 39035099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High YAP and TEAD4 immunolabelings are associated with poor prognosis in patients with gallbladder cancer.
    Kim JY; Sung YN; Hong SM
    APMIS; 2021 Dec; 129(12):729-742. PubMed ID: 34779030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and Functional Overview of TEAD4 in Cancer Biology.
    Chen M; Huang B; Zhu L; Chen K; Liu M; Zhong C
    Onco Targets Ther; 2020; 13():9865-9874. PubMed ID: 33116572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
    Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
    Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNF181 modulates Hippo signaling and triple negative breast cancer progression.
    Zhou R; Ding Y; Xue M; Xiong B; Zhuang T
    Cancer Cell Int; 2020; 20():291. PubMed ID: 32655323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics simulations study of influence of Tyr422Ala mutation on transcriptional enhancer activation domain 4 (TEAD4) and transcription co-activators complexes.
    Niu RJ; Zheng QC; Zhang HX
    J Theor Biol; 2019 Jul; 472():27-35. PubMed ID: 30978352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between TEAD4 and KLF5 promotes breast cancer partially through inhibiting the transcription of p27Kip1.
    Wang C; Nie Z; Zhou Z; Zhang H; Liu R; Wu J; Qin J; Ma Y; Chen L; Li S; Chen W; Li F; Shi P; Wu Y; Shen J; Chen C
    Oncotarget; 2015 Jul; 6(19):17685-97. PubMed ID: 25970772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo/TEAD4 signaling pathway as a potential target for the treatment of breast cancer.
    Wu Y; Li M; Lin J; Hu C
    Oncol Lett; 2021 Apr; 21(4):313. PubMed ID: 33692845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YAP transduction drives triple-negative breast cancer aggressiveness through modulating the EGFR‒AKT axis in patient-derived xenograft cells.
    Parambil ST; Thankayyan SKR; Antony GR; Littleflower AB; Augustine P; Somanathan T; Subhadradevi L
    Med Oncol; 2023 Apr; 40(5):137. PubMed ID: 37014473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational insights into the interaction mechanism of transcription cofactor vestigial-like protein 4 binding to TEA domain transcription factor 4 by molecular dynamics simulation and molecular mechanics generalized Born/surface area) calculation.
    Gao J; Zhang Y; Chen H; Chen Q; Feng D; Zhang L; Li C
    J Biomol Struct Dyn; 2019 Jul; 37(10):2538-2545. PubMed ID: 30051771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tea domain transcription factor TEAD4 mitigates TGF-β signaling and hepatocellular carcinoma progression independently of YAP.
    Luo W; Li Y; Zeng Y; Li Y; Cheng M; Zhang C; Li F; Wu Y; Huang C; Yang X; Kremerskothen J; Zhang J; Zhang C; Tu S; Li Z; Luo Z; Lin Z; Yan X
    J Mol Cell Biol; 2023 Jun; 15(2):. PubMed ID: 36806855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner.
    Liu Y; Wang G; Yang Y; Mei Z; Liang Z; Cui A; Wu T; Liu CY; Cui L
    Oncogene; 2016 May; 35(21):2789-800. PubMed ID: 26387538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional Enhancer Factor Domain Family member 4 Exerts an Oncogenic Role in Hepatocellular Carcinoma by Hippo-Independent Regulation of Heat Shock Protein 70 Family Members.
    Coto-Llerena M; Tosti N; Taha-Mehlitz S; Kancherla V; Paradiso V; Gallon J; Bianco G; Garofoli A; Ghosh S; Tang F; Ercan C; Christofori GM; Matter MS; Droeser RA; Zavolan M; Soysal SD; von Flüe M; Kollmar O; Terracciano LM; Ng CKY; Piscuoglio S
    Hepatol Commun; 2021 Apr; 5(4):661-674. PubMed ID: 33860124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An indispensable role of TAZ in anoikis resistance promoted by OTUB1 deubiquitinating enzyme in basal-like triple-negative breast cancer cells.
    Nakagawa H; Higurashi M; Ishikawa F; Mori K; Shibanuma M
    Biochem Biophys Res Commun; 2023 Mar; 649():1-9. PubMed ID: 36738577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis.
    Li Z; Su P; Ding Y; Gao H; Yang H; Li X; Yang X; Xia Y; Zhang C; Fu M; Wang D; Zhang Y; Zhuo S; Zhu J; Zhuang T
    Cell Commun Signal; 2022 Oct; 20(1):164. PubMed ID: 36280829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of YAP recognition by TEAD4 in the hippo pathway.
    Chen L; Chan SW; Zhang X; Walsh M; Lim CJ; Hong W; Song H
    Genes Dev; 2010 Feb; 24(3):290-300. PubMed ID: 20123908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational Design and Intramolecular Cyclization of Hotspot Peptide Segments at YAP-TEAD4 Complex Interface.
    Zhang D; He D; Pan X; Liu L
    Protein Pept Lett; 2020; 27(10):999-1006. PubMed ID: 32286937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the acylation of TEAD4 on its interaction with co-activators YAP and TAZ.
    Mesrouze Y; Meyerhofer M; Bokhovchuk F; Fontana P; Zimmermann C; Martin T; Delaunay C; Izaac A; Kallen J; Schmelzle T; Erdmann D; Chène P
    Protein Sci; 2017 Dec; 26(12):2399-2409. PubMed ID: 28960584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEAD4 as an Oncogene and a Mitochondrial Modulator.
    Hsu SC; Lin CY; Lin YY; Collins CC; Chen CL; Kung HJ
    Front Cell Dev Biol; 2022; 10():890419. PubMed ID: 35602596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization.
    Chen W; Bai Y; Patel C; Geng F
    Biochem Biophys Res Commun; 2019 Dec; 520(2):263-268. PubMed ID: 31590917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.